NATASHA WOODHAM: Open Payments
NPI 1073930947 · LYNN HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 13 payments from 7 companies in 2025. Trend: 2023 $485 · 2024 $332 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $144 |
| ABBVIE INC. | 3 | $70 |
| PFIZER INC. | 3 | $62 |
| Novo Nordisk Inc | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: CAPLYTA, NURTEC ODT, QULIPTA, JARDIANCE, UBRELVY, AIRSUPRA, Ozempic, Qelbree.
Industry payments across FL — which companies pay providers there.
